Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad)tc pixel

Demant A/S (OTCMKTS:WILYY) Sees Strong Trading Volume - Here's Why

Written by MarketBeat
Updated August 18, 2025
Demant A/S logo with Medical background

Key Points

  • Demant A/S shares experienced a significant increase in trading volume, with 3,225 shares traded on Wednesday, marking a 463% rise from the previous session.
  • Analysts have upgraded Demant A/S ratings, with Barclays changing from a "strong sell" to a "hold" and Citigroup moving from "hold" to a "strong buy," resulting in an average rating of "Buy".
  • The company operates in the hearing healthcare and audio technology sector, manufacturing and selling hearing aids and diagnostic products and services across multiple international markets.
  • MarketBeat previews the top five stocks to own by October 1st.

Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) saw an uptick in trading volume on Wednesday . 3,225 shares were traded during trading, an increase of 463% from the previous session's volume of 573 shares.The stock last traded at $18.99 and had previously closed at $19.27.

Wall Street Analyst Weigh In

Several research firms recently issued reports on WILYY. Citigroup raised shares of Demant A/S from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Barclays upgraded shares of Demant A/S from a "strong sell" rating to a "hold" rating in a research report on Friday, June 20th. Two investment analysts have rated the stock with a hold rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy".

View Our Latest Report on Demant A/S

Demant A/S Stock Performance

The stock has a fifty day simple moving average of $20.55 and a 200 day simple moving average of $18.86. The company has a current ratio of 1.63, a quick ratio of 1.22 and a debt-to-equity ratio of 1.29.

Demant A/S Company Profile

(Get Free Report)

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.

Read More

Should You Invest $1,000 in Demant A/S Right Now?

Before you consider Demant A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.

While Demant A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.